Clinical trial
Positron Emission Tomography and CT Scan in Predicting Response in Patients With…
NCT00316901 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00316901 |
|---|---|
| Title | Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial |
| Official title | PET/CT Evaluation of Subjects Treated on Surgery Branch Adoptive Cell Therapy Protocols |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Cancer, Melanoma (Skin) |
| Intervention type | Procedure, Radiation |
| Interventions | computed tomography, positron emission tomography, fludeoxyglucose F 18 |
| Enrollment | 70 |
| Start date | Apr 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Apr 21, 2006 |
| Last update posted | Mar 15, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: